The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text (PDF, 14K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
© The Rockefeller University Press, 0022-1007/1999/11/1363/ $5.00
The Journal of Experimental Medicine, Volume 190, Number 9, November 1, 1999 1363-1364


Correction


© 1999 The Rockefeller University Press

The authors regret an error in the second sentence of the legend to Fig. 1, which misstated the number of HIV-infected patients used for the illustration. The corrected text appears below and does not change the conclusions reported in the article.

Illustrated are the results (mean ± SEM) of 17 cocultures of heterologous PMNs or PBMCs (each 2 x 106) from low risk HIV-seronegative volunteers with 13 separate HIV-infected patients' mononuclear cells (2 x 106) in medium containing or lacking 10% IL-2. An additional 4 HIV-infected patients' mononuclear cells cocultured with cells from HIV-seronegative volunteers yielded low or no detectable p24 antigen and were not used for the illustration or analysis. The results are from seven separate experiments.





This Article
Right arrow Full Text (PDF, 14K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS